Pregnancy Outcomes in the Tofacitinib Safety Databases for Rheumatoid Arthritis and Psoriasis

INTRODUCTION: Tofacitinib is an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis (RA), and is being investigated for the treatment of psoriasis. Both conditions can present in women of child-bearing potential, but pregnancy was an exclusion and discontinuation criterion in tofac...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Drug Saf
Main Authors: Clowse, Megan E. B., Feldman, Steven R., Isaacs, John D., Kimball, Alexandra B., Strand, Vibeke, Warren, Richard B., Xibillé, Daniel, Chen, Yan, Frazier, Donald, Geier, Jamie, Proulx, James, Marren, Amy
Formato: Artigo
Idioma:Inglês
Publicado em: Springer International Publishing 2016
Assuntos:
Original Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4933738/
https://ncbi.nlm.nih.gov/pubmed/27282428
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40264-016-0431-z
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados